Search results for myod1

405 hits were found for myod1

# Family MCID Name MIFTS Score
1
MYP164 Myopathy, Congenital, with Diaphragmatic Defects, Respiratory Insufficiency, and Dysmorphic Facies 24 40.380
2
P RHB003 Rhabdomyosarcoma 66 24.755
3
P EMB005 Embryonal Rhabdomyosarcoma 53 17.371
4
c MYP123 Myopathy, Centronuclear, 1 52 16.476
5
P DST002 Distal Arthrogryposis 65 16.476
6
P MYP004 Myopathy 67 16.242
7
P MSC005 Muscular Dystrophy 67 15.651
8
ALV005 Alveolar Soft Part Sarcoma 61 15.542
9
P RTN024 Retinoblastoma 73 14.894
10
c MLG084 Malignant Fibrous Histiocytoma 62 14.583
11
PLM030 Pleomorphic Rhabdomyosarcoma 40 14.377
12
SPN009 Spindle Cell Rhabdomyosarcoma 39 14.059
13
c WLM013 Wilms Tumor 1 66 12.383
14
MSC157 Muscular Dystrophy, Duchenne Type 79 12.283
15
RHB024 Rhabdomyosarcoma 2 67 12.050
16
RHB001 Rhabdoid Cancer 68 11.954
17
EXT065 Extraosseous Ewing Sarcoma 29 11.283
18
P BCK002 Beckwith-Wiedemann Syndrome 62 11.153
19
P FCS012 Facioscapulohumeral Muscular Dystrophy 1 68 10.549
20
P BTR001 Botryoid Rhabdomyosarcoma 36 10.456
21
MSC007 Muscle Hypertrophy 64 10.289
22
DSM007 Desmoplastic Small Round Cell Tumor 54 9.992
23
P MSN005 Mesenchymal Chondrosarcoma 47 9.874
24
MLG014 Malignant Fibrous Histiocytoma of Bone 31 9.580
25
GLL021 Gallbladder Sarcoma 23 9.372
26
P FTL069 Fetal Akinesia Deformation Sequence 1 63 9.200
27
EMB007 Embryonal Sarcoma 40 9.016
28
OCL008 Oculopharyngeal Muscular Dystrophy 53 8.871
30
P MLG074 Malignant Mesenchymoma 40 8.275
31
PRS043 Prostate Rhabdomyosarcoma 29 8.069
32
c ADL019 Adult Fibrosarcoma 30 7.777
33
NRM005 Neuromuscular Disease 63 7.275
34
PRS010 Prostate Embryonal Rhabdomyosarcoma 26 7.141
35
BRS031 Breast Rhabdomyosarcoma 29 7.141
36
INF031 Inflammatory Leiomyosarcoma 25 7.141
37
UND001 Undifferentiated Embryonal Sarcoma of the Liver 31 6.982
38
SKL002 Skeletal Muscle Neoplasm 25 6.982
39
MSC072 Muscle Cancer 48 6.982
40
CNV006 Conventional Leiomyosarcoma 27 6.982
41
GSG001 Gas Gangrene 52 6.774
42
MSC190 Muscular Disease 37 6.774
43
MLG041 Malignant Triton Tumor 33 6.774
44
MSC152 Muscular Dystrophy, Becker Type 69 6.273
45
P RTN008 Retinitis Pigmentosa 80 6.273
46
c MYT021 Myotonic Dystrophy 1 68 6.273
47
XLN230 X-Linked Monogenic Disease 18 6.273
48
c INF085 Inflammatory Bowel Disease 27 31 6.273
49
SWN003 Sweeney-Cox Syndrome 39 6.273
50
c RTN114 Retinitis Pigmentosa 58 41 6.273
51
c EMR018 Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant 54 6.273
52
c HMP022 Hemophagocytic Lymphohistiocytosis, Familial, 1 66 6.273
53
XLN228 X-Linked Recessive Disease 24 6.273
54
c ATS331 Autosomal Recessive Limb-Girdle Muscular Dystrophy 40 6.273
55
LBR036 Leber Plus Disease 66 6.273
56
PNL015 Pineal Region Teratoma 22 6.273
57
SKL003 Skeletal Muscle Cancer 28 6.273
58
CRV028 Cervical Adenosarcoma 32 6.273
59
GLF001 Gliofibroma 32 6.273
60
TRN006 Transvestism 31 6.273
61
P EMR001 Emery-Dreifuss Muscular Dystrophy 62 6.273
62
BLD025 Bladder Sarcoma 30 6.273
63
MSC004 Muscle Tissue Disease 22 6.273
64
CNT042 Central Nervous System Mesenchymal Non-Meningothelial Tumor 21 6.273
65
EPD012 Epididymal Neoplasm 22 6.273
66
PLM003 Pulmonary Vein Leiomyosarcoma 21 6.273
67
PRS009 Prostate Stromal Sarcoma 28 6.273
68
CNV003 Conventional Fibrosarcoma 29 6.273
69
BLD023 Bladder Leiomyoma 32 6.273
70
SPR014 Spermatic Cord Cancer 19 6.273
71
SFT003 Soft Tissue Sarcoma 57 6.216
72
HLX001 Helix Syndrome 48 4.874
73
SRC014 Sarcoma 65 4.674
74
EWN003 Ewing Sarcoma 70 4.401
75
SPN035 Spindle Cell Sarcoma 54 4.113
76
P GST053 Gastric Cancer 83 3.918
77
P LMY004 Leiomyosarcoma 62 3.911
78
PLY150 Polykaryocytosis Inducer 29 3.677
79
P FBR003 Fibrous Histiocytoma 43 3.512
80
P NRB001 Neuroblastoma 66 3.463
81
P FBR017 Fibrosarcoma 56 3.183
82
P LNG064 Lung Cancer Susceptibility 3 70 2.925
83
P LNG032 Lung Cancer 98 2.719
84
OST159 Osteogenic Sarcoma 66 2.618
85
CRV035 Cervical Cancer 73 2.483
86
P MSC003 Muscular Atrophy 52 2.483
87
LYM143 Lymphoma, Non-Hodgkin, Familial 75 2.413
88
SVR004 Severe Combined Immunodeficiency 72 2.413
89
ECT002 Ectomesenchymoma 32 2.339
90
SRC027 Sarcoma, Synovial 58 2.180
91
MLG077 Malignant Peripheral Nerve Sheath Tumor 54 2.180
92
LYM007 Lymphangioleiomyomatosis 68 2.094
93
INF058 Inflammatory Myofibroblastic Tumor 45 2.094
94
ANG018 Angiomyolipoma 46 2.094
95
c CNG023 Congenital Fibrosarcoma 41 2.094
96
P ADN016 Adenocarcinoma 63 2.002
97
FSC004 Fasciitis 49 2.002
98
c RHB023 Rhabdomyosarcoma, Embryonal, 1 45 1.934
99
LMY002 Leiomyoma 51 1.904
100
P INF049 Infantile Myofibromatosis 55 1.904
101
PSD016 Pseudosarcomatous Fibromatosis 37 1.904
102
MLN071 Melanoma Tumor Antigen Gp90 17 1.797
103
P CHN012 Chondrosarcoma 57 1.737
104
c RTN041 Retinitis Pigmentosa 11 42 1.678
105
P SPP010 Suppressor of Tumorigenicity 3 51 1.678
106
RPD005 Rapidly Involuting Congenital Hemangioma 46 1.663
107
SML031 Small Cell Carcinoma of the Bladder 46 1.587
108
P RRT020 Rare Tumor 39 1.586
109
c GLC092 Glaucoma, Primary Open Angle 62 1.544
110
P OPN001 Open-Angle Glaucoma 55 1.544
111
P SPN046 Spinal Muscular Atrophy 63 1.544
112
P PRS040 Prostate Cancer 95 1.525
113
ADN011 Adenoid Cystic Carcinoma 68 1.459
114
GST040 Gastric Adenocarcinoma 67 1.459
115
RHB019 Rhabdomyosarcoma of the Cervix Uteri 12 1.418
116
c ATR087 Atrial Standstill 1 74 1.385
117
P MYG005 Myoglobinuria 40 1.385
118
SRC030 Sarcomatoid Carcinoma 42 1.327
119
CRC021 Carcinosarcoma 64 1.228
120
P TRT010 Teratoma 51 1.228
121
P GLM040 Glioma Susceptibility 1 71 1.124
122
GLM045 Glioma 63 1.124
123
RRS010 Rare Soft Tissue Tumor 18 1.121
124
PRS129 Prostatic Hyperplasia, Benign 49 1.121
125
SPP011 Suppression of Tumorigenicity 12 61 1.121
126
INS024 Insulin-Like Growth Factor I 78 1.121
127
P STR020 Strabismus 56 1.121
128
P SCL018 Scoliosis 57 1.121
129
MCH006 Mechanical Strabismus 40 1.121
130
ANG020 Angiosarcoma 64 1.121
131
PRS021 Prostatic Adenoma 43 1.121
132
PRS045 Prostatic Hypertrophy 53 1.121
133
GST103 Gastric Cancer, Hereditary Diffuse 68 1.055
134
LNG039 Lung Squamous Cell Carcinoma 57 1.023
135
P MYS003 Myasthenia Gravis 68 1.003
136
P LKM062 Leukemia, Acute Lymphoblastic 69 1.003
137
P EPT012 Epithelioid Sarcoma 41 1.003
138
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 1.003
139
P LPS002 Liposarcoma 64 1.003
140
CHR178 Chromosomal Triplication 34 1.003
141
ADN089 Adenosquamous Lung Carcinoma 49 0.957
142
END057 Endometrial Cancer 72 0.922
143
P TMR010 Tumor Predisposition Syndrome 67 0.922
144
SML009 Small Intestine Adenocarcinoma 57 0.922
145
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 0.922
146
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 0.886
147
c CLR087 Colorectal Cancer 12 34 0.886
148
PPL052 Papillomatosis, Confluent and Reticulated 34 0.868
149
c AMY091 Amyotrophic Lateral Sclerosis 1 88 0.868
150
CNG410 Congenital Heart Defects, Hamartomas of Tongue, and Polysyndactyly 61 0.868
151
P HMN036 Hemangiopericytoma, Malignant 58 0.868
152
GLL048 Glial Tumor 52 0.868
153
GLB002 Glioblastoma 67 0.868
154
P GST044 Gastritis 55 0.868
155
ADN018 Adenoma 59 0.868
156
P LTR001 Lateral Sclerosis 58 0.868
157
P MLN008 Melanoma 76 0.868
158
CLB002 Clubfoot 51 0.868
159
MLG169 Malignant Astrocytoma 57 0.868
160
P END044 Endometriosis 62 0.868
161
P MYT002 Myotonic Dystrophy 51 0.868
162
P NRF002 Neurofibromatosis 57 0.868
163
P BLD134 Bladder Cancer 79 0.863
164
GST019 Gastrointestinal Stromal Tumor 78 0.863
165
P BRS047 Breast Cancer 98 0.851
166
VNH007 Von Hippel-Lindau Syndrome 73 0.757
167
RNL114 Renal Cell Carcinoma, Nonpapillary 80 0.757
168
MNN043 Meningioma, Familial 79 0.757
169
MYP002 Myoepithelial Carcinoma 46 0.757
170
QLT002 Qualitative or Quantitative Defects of Dystrophin 19 0.709
171
CNG506 Congenital Amyoplasia 27 0.709
172
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.709
173
c MYS033 Miyoshi Muscular Dystrophy 1 52 0.709
174
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.709
175
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.709
176
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 0.709
177
P FML011 Familial Adenomatous Polyposis 71 0.709
178
FML037 Female Breast Cancer 51 0.709
179
CLT003 Colitis 63 0.709
180
DDF001 Dedifferentiated Liposarcoma 49 0.709
181
MYX013 Myxofibrosarcoma 44 0.709
182
P SML001 Small Cell Carcinoma 52 0.709
183
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 0.709
184
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 0.709
185
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.709
186
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 0.709
187
CHN056 Chondrosarcoma, Extraskeletal Myxoid 42 0.709
188
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.709
189
TBL029 Tubulin, Beta 28 0.709
190
P MDL005 Medulloblastoma 75 0.709
191
HRW001 Hair Whorl 35 0.709
192
P PLY041 Polymyositis 59 0.709
193
P EXT030 Extraosseous Chondrosarcoma 31 0.709
194
PRS042 Prostate Disease 42 0.709
195
EXP004 Exophthalmos 51 0.709
196
P ATR005 Atrophic Gastritis 50 0.709
197
ULC004 Ulcerative Colitis 74 0.709
198
NRN001 Neuroendocrine Carcinoma 47 0.709
199
CLR017 Clear Cell Sarcoma 44 0.709
200
P MYX008 Myxoid Chondrosarcoma 29 0.709
201
P PLC011 Pilocytic Astrocytoma 57 0.709
202
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.709
203
PLC002 Plica Syndrome 35 0.709
204
P LKM002 Leukemia 67 0.709
205
PGM001 Pigmented Villonodular Synovitis 55 0.709
206
P MYS079 Miyoshi Muscular Dystrophy 54 0.709
207
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 0.709
208
TNS001 Tenosynovial Giant Cell Tumor 40 0.709
209
SYN007 Synovitis 55 0.709
210
MSN004 Mesenchymal Cell Neoplasm 42 0.709
211
NRL005 Neurilemmoma 60 0.709
212
P BNG095 Benign Giant Cell Tumor 43 0.709
213
ADN020 Adenosarcoma 42 0.709
214
DYS032 Dystrophinopathies 47 0.709
215
VLL003 Villonodular Synovitis 41 0.709
216
c LKM005 Leukemia, T-Cell, Chronic 34 0.709
217
DCR010 Dicer1 Tumor Predisposition 30 0.709
219
HMN016 Hemangioendothelioma 34 0.709
220
FBR019 Fibromatosis 42 0.709
221
CLN015 Colon Adenocarcinoma 65 0.677
222
P PNC035 Pancreatic Cancer 86 0.602
223
ESP021 Esophageal Cancer 83 0.572
224
P EPT020 Epithelioid Hemangioendothelioma 44 0.501
225
c MNS014 Monosomy 22 35 0.501
226
TRT005 Teratoma with Malignant Transformation 16 0.501
227
P OVR082 Overgrowth Syndrome 49 0.501
228
THY128 Thyroid Tumor 35 0.501
229
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 0.501
230
RTN187 Retinitis Pigmentosa-Deafness Syndrome 48 0.501
231
ATX038 Ataxia and Polyneuropathy, Adult-Onset 46 0.501
232
c THY107 Thymoma, Familial 42 0.501
233
CRN296 Carnitine Palmitoyltransferase Ii Deficiency, Infantile 64 0.501
234
P PLR004 Pleuropulmonary Blastoma 65 0.501
235
MCR037 Macroglossia 44 0.501
236
P CLR023 Colorectal Cancer 100 0.501
237
c MGR028 Migraine with or Without Aura 1 64 0.501
238
NRD100 Neurodevelopmental, Jaw, Eye, and Digital Syndrome 49 0.501
239
ADR016 Adrenal Cortical Carcinoma 62 0.501
240
P ANP001 Anaplastic Large Cell Lymphoma 61 0.501
241
FCL022 Focal Dystonia 42 0.501
242
CRV043 Cervical Dystonia 46 0.501
243
DFF005 Diffuse Large B-Cell Lymphoma 54 0.501
244
BRR014 Barrett Esophagus 66 0.501
245
EPT029 Epithelioid Inflammatory Myofibroblastic Sarcoma 22 0.501
246
P OMP004 Omphalocele 48 0.501
247
CRV068 Cervical Polyp 27 0.501
248
P USH001 Usher Syndrome 64 0.501
249
CLR108 Colorectal Adenoma 64 0.501
250
CRD231 Cardiomyopathy, Infantile Histiocytoid 45 0.501
251
c LKM061 Leukemia, Acute Myeloid 83 0.501
252
c DPH024 Diaphragmatic Hernia, Congenital 64 0.501
253
RNL065 Renal Cell Carcinoma, Papillary, 1 79 0.501
254
CRB197 Carbonic Anhydrase Va Deficiency, Hyperammonemia Due to 57 0.501
255
HST022 Histiocytoma, Angiomatoid Fibrous 27 0.501
256
ADR054 Adrenocortical Carcinoma, Hereditary 47 0.501
257
DRM014 Dermatofibrosarcoma Protuberans 65 0.501
258
HMH004 Hemihyperplasia, Isolated 41 0.501
259
P PSD087 Pseudoxanthoma Elasticum 67 0.501
260
SRS007 Sorsby Fundus Dystrophy 51 0.501
261
INT051 Intussusception 52 0.501
262
PNM010 Pneumothorax, Primary Spontaneous 58 0.501
263
P HPT023 Hepatocellular Carcinoma 96 0.501
264
PRT010 Parathyroid Carcinoma 68 0.501
265
FBR054 Fibroma 44 0.501
266
ORL015 Oral Squamous Cell Carcinoma 43 0.501
267
OVR105 Ovarian Serous Carcinoma 37 0.501
268
MNC001 Monocular Esotropia 30 0.501
269
SNN002 Sinonasal Undifferentiated Carcinoma 30 0.501
270
PRT037 Pertussis 65 0.501
271
P BCL017 B-Cell Lymphoma 59 0.501
272
c CNT031 Central Epithelioid Sarcoma 30 0.501
273
PLM014 Pleomorphic Adenoma 51 0.501
274
GLL002 Gallbladder Angiosarcoma 9 0.501
275
EMB002 Embryoma 37 0.501
276
END031 Endometrial Stromal Sarcoma 45 0.501
277
MNP001 Monophasic Synovial Sarcoma 28 0.501
278
P DYS154 Dystonia 64 0.501
279
RHB002 Rhabdoid Meningioma 33 0.501
280
BRN018 Borna Disease 36 0.501
281
WLL039 Well-Differentiated Liposarcoma 40 0.501
282
CLL004 Cellular Myxoid Liposarcoma 30 0.501
283
PLM019 Pleomorphic Liposarcoma 40 0.501
284
CRV002 Cervix Uteri Carcinoma in Situ 47 0.501
285
ORB013 Orbital Disease 42 0.501
286
P MYL006 Myeloid Leukemia 61 0.501
287
HPT022 Hepatoblastoma 54 0.501
288
FND002 Fundus Dystrophy 55 0.501
289
PST092 Posttransplant Acute Limbic Encephalitis 28 0.501
290
EST005 Esotropia 43 0.501
291
47X002 47,xyy 48 0.501
292
P ALC033 Alcohol Use Disorder 61 0.501
293
P CYS018 Cystitis 59 0.501
294
ADR004 Adrenal Cortical Adenocarcinoma 38 0.501
295
PRS044 Prostate Sarcoma 25 0.501
296
CHL067 Cholecystitis 60 0.501
297
TRT001 Teratocarcinoma 42 0.501
298
P TRN020 Turner Syndrome 67 0.501
299
PNM008 Pneumothorax 54 0.501
300
MDL003 Medullomyoblastoma 34 0.501
301
OLF005 Olfactory Neuroblastoma 46 0.501
302
PLS011 Plasmacytoma 56 0.501
303
EPT008 Epithelioid Malignant Peripheral Nerve Sheath Tumor 24 0.501
304
P RTN016 Retinal Degeneration 52 0.501
305
MYF001 Myofibroma 42 0.501
306
SMN007 Seminoma 42 0.501
307
SCR001 Secretory Meningioma 40 0.501
308
LYM002 Lymphoplasmacyte-Rich Meningioma 35 0.501
309
MTN001 Metanephric Adenoma 40 0.501
310
ENC067 Encephalopathy, Progressive, Early-Onset, with Episodic Rhabdomyolysis 50 0.501
311
MCR011 Microinvasive Gastric Cancer 41 0.501
312
RCK004 Rickets 68 0.501
313
c FTL070 Fetal Akinesia Deformation Sequence 2 36 0.501
314
PPL022 Papilloma 53 0.501
315
MYP001 Myoepithelioma 37 0.501
316
P ADN017 Adenofibroma 34 0.501
317
LYM008 Lymphangiosarcoma 40 0.501
318
SQM002 Squamous Cell Papilloma 46 0.501
319
HYP068 Hyperostosis 47 0.501
320
CHL014 Cholera 62 0.501
321
ATY005 Atypical Teratoid Rhabdoid Tumor 69 0.501
322
HGH043 High Grade Glioma 45 0.501
323
GLS001 Gliosarcoma 64 0.501
324
MLG005 Malignant Spindle Cell Melanoma 39 0.501
325
PRV003 Perivascular Epithelioid Cell Tumor 38 0.501
326
P RSP003 Respiratory Failure 74 0.501
327
DSS009 Disseminated Intravascular Coagulation 57 0.501
328
TTN003 Tetanus 65 0.501
329
P HRN001 Horner's Syndrome 46 0.501
330
P PLY011 Polycystic Ovary Syndrome 57 0.501
331
MNN009 Meningoencephalitis 48 0.501
332
MCR013 Microphthalmia 60 0.501
333
P BLP003 Blepharospasm 46 0.501
334
c MLG081 Malignant Teratoma 38 0.501
335
BRS007 Breast Malignant Phyllodes Tumor 45 0.501
336
c ACT071 Acute Kidney Failure 60 0.501
337
NPH006 Nephrogenic Adenofibroma 21 0.501
338
P THY023 Thymoma 64 0.501
339
P BNG032 Benign Mesothelioma 53 0.501
340
P GND004 Gonadal Dysgenesis 47 0.501
341
SPN021 Spinal Meningioma 50 0.501
342
P AXN002 Axenfeld-Rieger Syndrome 63 0.501
343
PLR022 Pleural Disease 45 0.501
344
P BNG013 Benign Breast Phyllodes Tumor 35 0.501
345
P OVR049 Ovarian Disease 52 0.501
346
RCT020 Rectum Adenocarcinoma 48 0.501
347
c HPT016 Hepatitis B 62 0.501
348
PNC008 Pancreatic Endocrine Carcinoma 39 0.501
349
ISL001 Islet Cell Tumor 56 0.501
350
CLC006 Calcinosis 47 0.501
351
HYP060 Hyperinsulinism 54 0.501
352
NRN004 Neuroendocrine Tumor 59 0.501
353
KLD004 Keloid Disorder 39 0.501
354
P INS002 in Situ Carcinoma 53 0.501
355
ORP003 Oropharynx Cancer 55 0.501
356
GRM010 Germ Cells Tumors 33 0.501
357
HYP056 Hypoglycemia 65 0.501
358
NRF007 Neurofibroma 64 0.501
359
P EPS003 Episodic Ataxia 59 0.501
360
P HYP265 Hypotonia 42 0.501
361
HYP266 Hypoxia 57 0.501
362
CRV045 Cervical Intraepithelial Neoplasia 39 0.501
363
ANP011 Anaplastic Small Cell Lymphoma 12 0.501
364
CHR176 Chromophil Renal Cell Carcinoma 23 0.501
365
NNS011 Nonseminomatous Germ Cell Tumor 33 0.501
366
GGN002 Gigantism 33 0.501
367
c PRS097 Prostate Cancer, Hereditary, 1 39 0.443
368
c PRS070 Prostate Cancer, Hereditary, 12 22 0.443
369
c PRS071 Prostate Cancer, Hereditary, 13 25 0.443
370
c PRS117 Prostate Cancer, Hereditary, 11 24 0.443
371
c PRS114 Prostate Cancer, Hereditary, 2 33 0.443
372
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.443
373
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 21 0.443
374
BRS099 Breast Ductal Carcinoma 61 0.443
375
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.443
376
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.362
377
P LNG021 Lung Occult Small Cell Carcinoma 20 0.362
378
LNG019 Lung Combined Type Small Cell Carcinoma 32 0.362
379
P LFR001 Li-Fraumeni Syndrome 73 0.256
380
c GLM047 Glioma Susceptibility 3 33 0.256
381
LNG115 Lung Sarcomatoid Carcinoma 36 0.256
382
c MSM022 Mismatch Repair Cancer Syndrome 1 70 0.256
383
c GLM025 Glioma Susceptibility 2 30 0.256
384
c GLM043 Glioma Susceptibility 9 30 0.256
385
c RHB021 Rhabdomyosarcoma, Embryonal, 2 24 0.256
386
LNG091 Lung Mucoepidermoid Carcinoma 32 0.256
387
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.256
388
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 32 0.256
389
LNG003 Lung Carcinoma in Situ 36 0.256
390
BSL003 Basaloid Lung Carcinoma 35 0.256
391
P OLG002 Oligodendroglioma 66 0.256
392
CLR030 Clear Cell Renal Cell Carcinoma 54 0.256
393
P LNG035 Lung Large Cell Carcinoma 54 0.256
394
LNG011 Lung Adenoid Cystic Carcinoma 35 0.256
395
CRV013 Cervical Adenoid Cystic Carcinoma 33 0.256
396
PPL004 Papillary Squamous Carcinoma 39 0.256
397
LNG020 Lung Oat Cell Carcinoma 51 0.256
398
EPT010 Epithelial-Myoepithelial Carcinoma 55 0.256
399
LNG017 Lung Giant Cell Carcinoma 52 0.256
400
c LNG001 Lung Clear Cell Carcinoma 29 0.256
401
LNG006 Lung Occult Large Cell Carcinoma 14 0.256
402
LNG002 Lung Combined Large Cell Neuroendocrine Carcinoma 19 0.256
404
HLR002 Hilar Lung Carcinoma 24 0.256
405
LNG014 Lung Superior Sulcus Carcinoma 15 0.256
Content
Loading form....